BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34978241)

  • 1. Gut inflammation in CVID: causes and consequences.
    Andersen IM; Jørgensen SF
    Expert Rev Clin Immunol; 2022 Jan; 18(1):31-45. PubMed ID: 34978241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions.
    Varricchi G; Poto R; Ianiro G; Punziano A; Marone G; Gasbarrini A; Spadaro G
    Front Immunol; 2021; 12():712915. PubMed ID: 34408753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy.
    Mohammed AD; Khan MAW; Chatzistamou I; Chamseddine D; Williams-Kang K; Perry M; Enos R; Murphy A; Gomez G; Aladhami A; Oskeritzian CA; Jolly A; Chang Y; He S; Pan Z; Kubinak JL
    Front Immunol; 2019; 10():2484. PubMed ID: 31708923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences.
    Berbers RM; Nierkens S; van Laar JM; Bogaert D; Leavis HL
    Trends Immunol; 2017 Mar; 38(3):206-216. PubMed ID: 28017520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications.
    Jørgensen SF; Fevang B; Aukrust P
    J Clin Immunol; 2019 Jan; 39(1):30-36. PubMed ID: 30465180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
    Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
    Front Immunol; 2020; 11():574500. PubMed ID: 33042155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency.
    Jørgensen SF; Reims HM; Frydenlund D; Holm K; Paulsen V; Michelsen AE; Jørgensen KK; Osnes LT; Bratlie J; Eide TJ; Dahl CP; Holter E; Tronstad RR; Hanevik K; Brattbakk HR; Kaveh F; Fiskerstrand T; Kran AB; Ueland T; Karlsen TH; Aukrust P; Lundin KE; Fevang B
    Am J Gastroenterol; 2016 Oct; 111(10):1467-1475. PubMed ID: 27527747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal inflammation in common variable immunodeficiency has altered transcriptional response to viruses.
    Kaarbø M; Yang M; Hov JR; Holm K; de Sousa MML; Macpherson ME; Reims HM; Kran AB; Halvorsen B; Karlsen TH; Aukrust P; Lundin KEA; Fevang B; Bjørås M; Jørgensen SF
    J Allergy Clin Immunol; 2023 Mar; 151(3):767-777. PubMed ID: 36220400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary: Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy.
    Jørgensen SF; Fevang B; Aukrust P
    Front Immunol; 2020; 11():1921. PubMed ID: 32983117
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of HLA DQ2 and DQ8 in dissecting celiac-like disease in common variable immunodeficiency.
    Venhoff N; Emmerich F; Neagu M; Salzer U; Koehn C; Driever S; Kreisel W; Rizzi M; Effelsberg NM; Kollert F; Goldacker S; Voll RE; Warnatz K; Thiel J
    J Clin Immunol; 2013 Jul; 33(5):909-16. PubMed ID: 23609110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont.
    Shulzhenko N; Dong X; Vyshenska D; Greer RL; Gurung M; Vasquez-Perez S; Peremyslova E; Sosnovtsev S; Quezado M; Yao M; Montgomery-Recht K; Strober W; Fuss IJ; Morgun A
    Clin Immunol; 2018 Dec; 197():139-153. PubMed ID: 30240602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
    Jørgensen SF; Macpherson ME; Bjørnetrø T; Holm K; Kummen M; Rashidi A; Michelsen AE; Lekva T; Halvorsen B; Trøseid M; Mollnes TE; Berge RK; Yndestad A; Ueland T; Karlsen TH; Aukrust P; Hov JR; Fevang B
    Sci Rep; 2019 Jan; 9(1):167. PubMed ID: 30655568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial but Not Fungal Gut Microbiota Alterations Are Associated With Common Variable Immunodeficiency (CVID) Phenotype.
    Fiedorová K; Radvanský M; Bosák J; Grombiříková H; Němcová E; Králíčková P; Černochová M; Kotásková I; Lexa M; Litzman J; Šmajs D; Freiberger T
    Front Immunol; 2019; 10():1914. PubMed ID: 31456808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for microbiome-based approach in common variable immunodeficiency?
    Poto R; Laniro G; de Paulis A; Spadaro G; Marone G; Gasbarrini A; Varricchi G
    Clin Exp Med; 2023 Oct; 23(6):1981-1998. PubMed ID: 36737487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency.
    Macpherson ME; Skarpengland T; Hov JR; Ranheim T; Vestad B; Dahl TB; Fraz MSA; Michelsen AE; Holven KB; Fevang B; Berge RK; Aukrust P; Halvorsen B; Jørgensen SF
    J Clin Immunol; 2023 Aug; 43(6):1229-1240. PubMed ID: 36995502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Expert Opinion/Approach: Clinical Presentations, Diagnostic Considerations, and Therapeutic Options for Gastrointestinal Manifestations of Common Variable Immune Deficiency.
    Hashash JG; Squire J; Francis FF; Binion DG; Cross RK; Farraye FA
    Am J Gastroenterol; 2022 Nov; 117(11):1743-1752. PubMed ID: 36148549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal Immunoglobulin Levels as a Modifier of the Gut Microbiome in Patients with Common Variable Immunodeficiency.
    Nöltner C; Bulashevska A; Hübscher K; Haberstroh H; Grimbacher B; Proietti M
    J Clin Immunol; 2023 Aug; 43(6):1208-1220. PubMed ID: 36961604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota.
    Cabanero-Navalon MD; Garcia-Bustos V; Mira A; Moral Moral P; Salavert-Lleti M; Forner Giner MJ; Núñez Beltrán M; Todolí Parra J; Bracke C; Carda-Diéguez M
    Clin Immunol; 2023 Nov; 256():109796. PubMed ID: 37774905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease.
    Malamut G; Verkarre V; Suarez F; Viallard JF; Lascaux AS; Cosnes J; Bouhnik Y; Lambotte O; Béchade D; Ziol M; Lavergne A; Hermine O; Cerf-Bensussan N; Cellier C
    Am J Gastroenterol; 2010 Oct; 105(10):2262-75. PubMed ID: 20551941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A High Prevalence of Gastrointestinal Manifestations in Common Variable Immunodeficiency.
    Pikkarainen S; Martelius T; Ristimäki A; Siitonen S; Seppänen MRJ; Färkkilä M
    Am J Gastroenterol; 2019 Apr; 114(4):648-655. PubMed ID: 30747770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.